AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Lifecare ASA

Board/Management Information Dec 19, 2023

3654_rns_2023-12-19_4891222a-8c37-42a4-a70e-73a3141854d8.pdf

Board/Management Information

Open in Viewer

Opens in native device viewer

LIFE: PROF. DR. TONY JAMES JOINING LIFECARE'S SCIENTIFIC ADVISORY BOARD

Professor Dr. Tony James will join Lifecare's Scientific Advisory Board. - We have collaborated with Professor Tony James since 2019, and we are really excited to bring him on board in this position, says CEO Joacim Holter.

Tony James is professor of Chemistry at the University of Bath and Fellow of the Royal Society of Chemistry. He has received the Daiwa-Adrian Prize for developing scientific links with Japan, the CASE Prize for establishing scientific networks with China, the MSMLG Czarnik Award, the Frontiers in Chemistry Diversity Award and a Royal Society Wolfson Research Merit Award. He is also listed by Clarivate as a Highly Cited Researcher in Chemistry.

– Tony James has an outstanding academic record. He has published over 470 publications, including three books, 10 book chapters and 457 papers in international peer reviewed journals. Professor James is also the named inventor on 30 international patents and has delivered 266 invited lectures within the UK and internationally. He is a remarkable asset for Lifecare, Holter points out.

The CEO of Lifecare states that he is very pleased that Prof James will now add valuable insight within his area of expertise to our highly competent Scientific Advisory Board.

Lifecare's Scientific Advisory Board is chaired by the distinguished Prof. David C. Klonoff: https://lifecare.no/about-lifecare/#scientificadv

About us

Lifecare AS is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's main focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on the sensor body for read-out of pressure variations. Lifecare's sensor technology is referred to as "Sencell" and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs, [email protected], +47 41 61 42 52

Talk to a Data Expert

Have a question? We'll get back to you promptly.